Can enoxaparin prevent arthrofibrosis?

International Journal of Clinical Pharmacology and Therapeutics

Volumn 50, Issue 1, 2012, Pages 49-50

  Emami, Mohammad Jafar ^a   Namazi, Hamid ^a   Vosoughi, Amir Reza ^a   Nezhad, Simin Torabi ^b   Oryan, Ahmad ^c   Mozaffarian, Kamran ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHROFIBROSIS; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; DRUG EFFECT; FIBROSIS; HISTOPATHOLOGY; JOINT STIFFNESS; LETTER; NONHUMAN; TISSUE ADHESION; TISSUE DISTRIBUTION;

ANIMALS; ENOXAPARIN; FIBRINOLYTIC AGENTS; FIBROSIS; JOINT DISEASES; KNEE JOINT; MALE; ORTHOPEDIC PROCEDURES; POSTOPERATIVE COMPLICATIONS; RABBITS;

EID: 84855162296     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP201638     Document Type: Letter

References (12)

1. Weitz JI. Low-molecular-weight heparins. N Engl J Med. 1997; 337: 688-698. doi:10.1056/ NEJM199709043371007 PubMed
2. Oken OF, Yildirim AO, Gulcek M, Unal VS, Karakuyu A, Ozlu K, Ucaner A. The effect of prophylactic dose of a low molecular weight heparin on skin wound healing of rats. Acta Cir Bras. 2009; 24: 471-475. doi:10.1590/S0102- 86502009000600009 PubMed
3. Arikan S, Adas G, Barut G, Toklu AS, Kocakusak A, Uzun H, Kemik O, Daduk Y, Aydin S, Purisa S. An evaluation of low molecular weight heparin and hyperbaric oxygen treatment in the prevention of intra-abdominal adhesions and wound healing. Am J Surg. 2005; 189: 155-160. doi:10.1016/j.amjsurg.2004.11.002 PubMed (Pubitemid 40255104)
4. Abe W, Ikejima K, Lang T, Okumura K, Enomoto N, Kitamura T, Takei Y, Sato N. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat. J Hepatol. 2007; 46: 286-294. doi:10.1016/j. jhep.2006.08.023 PubMed
5. Huang JS, Luo X, Yu JX, Liu W, Chen XW, Xie L, Zhu XY, Chen GY. Indigenous and imported low molecular weight heparin in the treatment of chronic hepatitis B and cirrhosis with hepatitis B virus: a prospective randomized controlled clinical study. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007; 19: 408-411. PubMed (Pubitemid 47180151)
6. Frizelle S, Schwarz J, Huber SA, Leslie K. Evaluation of the effects of low molecular weight heparin on inflammation and collagen deposition in chronic coxsackievirus B3-induced myocarditis in A/J mice. Am J Pathol. 1992; 141: 203-209. PubMed
7. Iverson DA, Daily WA, Hartzer M, Chapman C. The effect of low molecular weight heparin on the mitogenicity of intraocular fluid from patients with proliferative retinopathies. Invest Ophthalmol Vis Sci. 1991; 32 (Suppl): 819.
8. Rothkopf DM, Webb S, Szabo RM, Gelberman RH, May JW Jr. An experimental model for the study of canine flexor tendon adhesions. J Hand Surg Am. 1991; 16: 694-700. doi:10.1016/0363-5023(91)90196-I PubMed
9. Ergul E, Korukluoglu B. Peritoneal adhesions: facing the enemy. Int J Surg. 2008; 6: 253-260. doi:10.1016/j.ijsu.2007.05.010 PubMed (Pubitemid 351799984)
10. Assy N, Hussein O, Khalil A, Luder A, Szvalb S, Paizi M, Spira G. The beneficial effect of aspirin and enoxaparin on fibrosis progression and regenerative activity in a rat model of cirrhosis. Dig Dis Sci. 2007; 52: 1187-1193. doi:10.1007/ s10620-006-9595-1 PubMed
11. Laxer U, Lossos IS, Gillis S, Or R, Christensen TG, Goldstein RH, Breuer R; U. Laxer, I. S. Lossos, S. Gillis. The effect of enoxaparin on bleomycin-induced lung injury in mice. Exp Lung Res. 1999; 25: 531-541. doi:10.1080/019021499270114 PubMed (Pubitemid 29451408)
12. Ergul E, Ozgun YM, Kiyak G, Barit Ozgun G, Korukluoglu B, Kusdemir A. Does low molecular weight heparin impair anastomotic wound healing? J Gastrointest Surg. 2009; 13: 798-803. doi:10.1007/s11605-008-0771-9 PubMed